Powered by IBIS Capital, HealthTechX 2023 will bring together a curated attendee list of founders, investors, corporate leaders, operators, opinion leaders and policy makers leading the way for innovation in healthcare to discuss the digitisation of pharma. 

A distinguished Advisory Board has played a key role in shaping the HealthTechX Summit programme. It’s a guarantee to our attendees that the topics covered and the speakers on the programme represent the cutting-edge industry debate. From guiding our editorial calendar to helping shape our event, the Board is our expert connection to the industry, and they will share their combined experience and know-how with us. 

The agenda will offer eye-opening keynotes, engaging panel discussions and interactive firesides led by organisations at the forefront of digital innovation in the sector with companies including Astellas, AstraZeneca, Bayer, Biogen, GSK, Huma, Our Future Health, Oviva, Sweetch and many more. Bringing together a variety of perspectives and experiences, the speakers will offer their unique insights on topics including Pharma-HealthTech partnerships and the growing importance of digital therapeutics, as well as key challenges such as health equity and patient adherence. Follow the link to explore the full agenda  

Through insightful thought-leadership content, exclusive networking opportunities, an extended sit-down lunch and closing cocktail reception, HealthTechX provides a unique environment for creating invaluable connections and sharing knowledge. 

HealthTechX is pleased to offer a 60% startup ticket discount* for Startups Magazine readers wishing to attend. Please apply the promo code STARTUPMAG60 when registering on the ticket registration page here

*Discount valid until 31st January 2023 

About HealthTechX 

The team behind the highly successful EdTechX event series are reigniting the HealthTechX brand with the support of founding partner IBIS Capital, the specialist investment and corporate finance advisory group. With the recent release of their HealthTechX Global Report on the Digitisation of Pharma and the announcement of IBIS’ advisory services enabling Docquity’s 44$m Series C investment round, the firm continues to demonstrate its leading position in the HeathTech sector and looks forward to powering the 2023 HealthTechX Summit.  

HealthTechX Reports, Insights & Awards 

In addition to our thought leadership summits, we share the latest industry insights, trends and ideas through a series of editorials, articles and reports — keeping the global health technology community up to date on the positive impact that technology is having across the sector. 

HealthTechX Global Report: Digitisation of Pharma  

IBIS Capital’s latest industry research report, the HealthTechX Global Report: Digitisation of Pharma includes an 80-page deep dive into the pharmaceutical industry’s move towards digitisation and the innovative digital health businesses enabling their evolution. The report analyses 1,300+ digital health companies across 6 segments and includes data across 3,500+ transactions and 30+ IPOs. It covers M&A and fundraising trends, business models, key trends and investment outlook. 
 
Follow the link to download the report for free  

HealthTechX Stories 

The newly launched digital series, ‘HealthTechX Stories’ are short interactions with CEOs, founders, investors, and innovators who are reimagining the future of global health. These video snapshots provide quick, digestible pieces of content that offer audiences further insight into what is happening in the sector globally, as well as highlight our guests’ inspirations, moments that have shaped their lives, personal perspectives and predictions on healthcare. 

Follow the link to watch all the HealthTechX Stories

HealthTechX Awards 

The HealthTechX Awards aim to showcase and celebrate the startups and scaleups that are leading transformation across the global health technology industry. Determined by the IBIS Capital team and our Award Sponsors and Partners, applicants are evaluated on various factors including revenue growth, scale, innovation, future business prospects, and impact.  

Prospective businesses are invited to submit their application for consideration before the deadline of 15th January 2023. The finalists and winners will be announced at the HealthTechX Summit on 23 February 2023. 

Follow the link to find out more and submit your application